-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on NeuroPace, Lowers Price Target to $12

Benzinga·11/16/2026 12:11:05
HC Wainwright & Co. analyst Yi Chen maintains NeuroPace (NASDAQ:NPCE) with a Buy and lowers the price target from $20 to $12.